NEW YORK - Immunocore yakati Muvhuro ichatengesa 3,733,333 shares mune yakavanzika equity investment (PIPE) chibvumirano chemari inotarisirwa kukwidza madhora zana nemakumi mana emamiriyoni.
Pasi pechibvumirano, Immunocore ichatengesa masheya ayo akajairika uye asiri ekuvhota akajairika masheya emadhora makumi matatu nemakumi mashanu neshanu.Vashandi vekambani varipo vari kutora chikamu mumari iyi vanosanganisira RTW Investments, Rock Springs Capital uye General Atlantic.Chibvumirano chePIPE chinotarisirwa kupera musi wa20 Chikunguru.
Kambani iyi ichashandisa mari iyi kutsigira vamiriri vepombi yeoncology uye chirwere chinotapukira, kusanganisira kuvandudzwa kweanotungamira oncology mumiriri, Kimmtrak (tebentafusp-tebn), kurapa HLA-A * 02:01 ganda rakanaka uye uveal melanoma. Mari, pamwe nemari kubva kuKimmtrak, inotarisirwa kupa mari yeImmunocore2025 kuburikidza nekushanda kweImmunocore2025.
Gore rino, Kimmtrak yakagamuchirwa kuti ishandiswe kune varwere vane HLA-A * 02: 01 yakanaka isingagadziriswi kana metastatic uveal melanoma muU.
Immunocore iri kugadzirawo mamwe maoncology mana, kusanganisira maviri ekuwedzera T-cell receptor mishonga muPhase I / II miedzo mumamota akasimba akasimba.Imwe yemishonga iri kugadzirwa kune HLA-A * 02:01-positive uye MAGE-A4-positive varwere, uye zvimwe zvinonangwa HLA-A * 02:01 uye PRAME-positive-positive ine matundu maviri epamberi mukiriniki yakavharwa.
Privacy Policy.terms and Conditions.Copyright © 2022 GenomeWeb, chikamu chebhizimusi cheCrain Communications.kodzero dzese dzakachengetwa.